Hints and tips:
Related Special Reports
...I’m into self-replication.”...
...Other institutional funds managers, including M&G and Schroders, also deferred withdrawal requests and have yet to lift their blocks....
...Crevoiserat: [We] are still very confident in terms of how we’ve positioned the business, positioned our inventories, and positioned our innovation pipeline to speak to consumers in the world and in the...
...M&G Investments’ annual bond forum in London earlier this year featured an unusual presence on the stage: a large colourful statue of an elephant....
...I’m not sure of the market relevance of either point, but there you go. Email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...M&G said: “We considered a range of options but as an active asset manager, the only alternative passive M&G fund available was not suitable given it tracks the FTSE All-Share index, which offers significantly...
...But any barriers to M&A would make it harder for pharma giants to smooth their earnings and pay generous dividends....
...“Transformative M&A has arrived,” Jefferies analyst Dan Fannon wrote in a note....
...That’s the mission I’m on.” Most of the $12.5bn price tag will be paid in BlackRock shares, and 40 per cent will not vest for five years....
...drugs and ensuring a pipeline of new therapies....
...Pfizer has agreed to acquire oncology-focused biotech Seagen for a total enterprise value of $43bn as the US pharmaceutical company refills its drugs pipeline amid a sharp fall in sales of its Covid-19 products...
...He is observing what others are observing,” said Vine at M&G. “I’m very excited” by the outlook, he added....
...Barriers to M&A are going to make it harder for pharma companies to replenish drug pipelines. The tech sector faces the same issue....
...“I’m glad the FTC is looking at this,” Schleifer told the Financial Times US pharma and biotech summit in New York....
...When announcing the transaction last year, Amgen had said that Horizon’s pipeline of medicines would “strongly complement” its R&D portfolio....
...Pfizer also has plenty of options to replenish its pipeline through M&A due to cash reserves amassed from sales of its Covid vaccines and drugs, she said....
...“Prometheus takeout [is] likely a positive for Merck and broader Pharma sector, as M&A activity has begun to thaw,” he said....
...As for the impact upon financial markets and the business environment, although the failed mutiny commanded headlines, I’m not expecting a major dislocation from markets Monday....
...M&G said its £4.6bn Secured Property Income fund, which is largely owned by defined benefit pension schemes, is still deferring withdrawals....
...His firm G Asset Management had very little money, but it did have some short-term call options on the stock, so the SEC charged him with fraud....
...“I’m totally relaxed about it. It’s something that will probably come while I’m chair but if possible in the later years,” he said of the day when Soriot eventually departs....
...I’m going to make way, way more from other investments that I’ve made in the past,” he said at a recent event hosted by Bloomberg in San Francisco. Could Oklo be one of them?...
...The planned Power of Siberia-2 gas pipeline would further cement ties....
...“I have never seen anything like what I’m seeing now....
...While there has been a broader slowdown in M&A this year, drugmakers have been busy putting their large piles of cash to work as they seek to replenish their drug pipelines....
International Edition